Pigmentation due to the synthesis and dispersion of melanin protects the skin from the harmful effects of sunlight, 1) but unwanted hyperpigmentation can also produce significant psychological stress. Melanin is synthesized in the melanosomes in melanocytes, which produce melanin by a process that involves the transformation of tyrosine into 3,4-dihydroxyphenylalanine (L-DOPA) by the enzyme tyrosinase and the subsequent transformation of L-DOPA into melanin. 2, 3) Tyrosinase is the key enzyme in the pathway of melanogenesis, and plays a regulatory role in the production of melanin. [4] [5] [6] Accordingly, the regulation of tyrosinase may not only control melanin production but also provide a strategy for modulation of unwanted hyperpigmentation. Various agents have been screened for their effectiveness in reducing melanogenesis, such as hydroquinone and kojic acid, which have been reported as tyrosinase inhibitors. 7, 8) However, these compounds have side effects, such as the adverse cutaneous toxicity of hydroquinone and tumor-promoting effect of kojic acid. 9, 10) Thus there has been increasing impetus to develop alternative hypopigmenting agents.
Amino acids are important molecules that participate in multiple biochemical processes in mammals. Glycine is the simplest of the nonessential amino acids, and dietary glycine intake may have beneficial effects. [11] [12] [13] We previously demonstrated that glycine inhibits spontaneous melanogenesis in B16F0 melanoma cells, similar to kojic acid, which is a typical tyrosinase inhibitor. 14) However, in that study, glycine did not affect crude tyrosinase activity, therefore the mechanisms of the inhibitory effect of glycine on melanogenesis are unclear.
a-Melanocyte stimulating hormone (a-MSH) is one of the major propigmentation hormones, and synthesis of a-MSH is an important determinant of constitutive pigmentation and the cutaneous response to UV. [15] [16] [17] Following UV-exposure, a-MSH is produced and secreted by both keratinocytes and melanocytes in the skin. 16, 18) Therefore, a-MSH-induced melanogenesis in melanoma cells is thought to be a good in vitro model for UV-induced pigmentation.
On the other hand, the number of in vivo experimental models of pigmentation is limited. C57BL/6J mice have been used, as they have depilation-induced hair follicle cycling and show hair pigmentation. 19) The hair follicle passes through three key cyclic regeneration stages, telogen, anagen and catagen. 20) Plucking of hair initiates the anagen phase of the hair cycle, followed by activation of follicular melanocytes and high tyrosinase activity. 21) Treatment with phenolic derivatives, a substrate for tyrosinase, causes hypopigmentation of newly grown hair in C57BL/6J mice. 22) Therefore, the melanogenesis of hair follicles in C57BL/6J mice has been recognized as a useful model for researching pigmentation in vivo. 19, 23, 24) The present study was performed to investigate the mechanisms of the inhibitory effect of glycine on melanogenesis using a-MSH-induced melanogenesis in B16F0 melanoma cells and hair follicle melanogenesis in C57BL/6J mice.
hibitor Cocktail Kit and BCA TM Protein Assay Kit were purchased from PIERCE (Rockford, IL, U.S.A.). The antibodies used were as follows: polyclonal anti-tyrosinase (C-19: sc-7833), polyclonal anti-GAPDH (V-18: sc-20357) and horseradish peroxidase-conjugated donkey anti-goat IgG antibody (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.).
Animals Female C57BL/6J mice (18-22 g) were purchased from Charles River Japan, Inc. (Tokyo, Japan). Mice were housed eight per cage with food and water available ad libitum in the Laboratory Animals Facility. The facility was maintained on a 12-h light/dark cycle (lights on from 07:00-19:00) under standard conditions (23Ϯ1°C room temperature, 50% humidity). The mice were kept in a holding room for 7 d following arrival at the facility. This research was approved by the Institutional Animal Care and Use Committee and was carried out in accordance with the Guideline for the Care and Use of Laboratory Animals adopted and promulgated by the Japanese Ministry of Health, Labour and Welfare. All efforts were made to minimize the number of animals used and their suffering.
Cell Culture B16F0 melanoma cells were cultured in DMEM supplemented with 10% FBS, 100 U/ml penicillin and 100 mg/ml streptomycin, and incubated at 37°C under 5% CO 2 atmosphere. The cells were detached from culture bottles using 0.025% trypsin and 0.5 mM ethylenediaminetetraacetic acid (EDTA) in phosphate-buffered saline (PBS). B16F0 melanoma cells were seeded into 6-well plates at a density of 10 5 cells per well and allowed to attach overnight. Each dose of sample reagent and a-MSH was added to a well and incubated for another 72 h. After each incubation, cells were washed with cold PBS. The cells were then dissolved in 400 ml of 1 N NaOH at 80°C for 1 h and their melanin content measured. In the other set of experiments, the cells were dissolved in 400 ml of M-PER Mammalian Protein Extraction Reagent with Halt TM Protease Inhibitor Cocktail Kit, and then disrupted by freezing and thawing 5 times. The lysates were clarified by centrifugation at 10000 g for 5 min and used for analysis of tyrosinase protein levels.
Measurement of Skin Pigmentation C57BL/6J mice were anesthetized with a ketamine-xylazine mixture (80 and 16 mg/kg, i.p., respectively) to depilate the entire hair of the back using a bee's wax-rosin mixture on day 0 as previously described. 24) Each dose of sample reagent was administered i.p. once daily for 5 d from 3 d after depilation. On days 0, 3, 5 and 7, the pigmentation of the skin was determined using a Color Reader CR-11 MUNSELL (Minolta, Osaka, Japan) and was expressed as L* and C* values. The C* value was calculated from the a* and b* values, according to the following formula:
The L* value represents the lightness of the color (L*ϭ0 indicates black, L*ϭ100 indicates white), the C* value represents the saturation of color between gray (lowest value) and vivid (highest value), the a* value represents the color position between magenta (positive values) and green (negative values), and the b* value represents the color position between yellow (positive values) and blue (negative values). 25) On days 0 and 7, a skin sample (10 mm diameter) was taken from the back of the mice. The sample was homogenized in T-PER Tissue Protein Extraction Reagent with Halt TM Protease Inhibitor Cocktail Kit. The homogenate of each sample was centrifuged 3 times at 10000 g for 5 min each, after which the supernatant was used to evaluate tyrosinase protein levels. The pellet was then dissolved in 500 ml of 1 N NaOH at 100°C for 30 min and used for measurement of melanin content.
Melanin Measurement Melanin content was measured as described previously with slight modifications.
26) The absorbance of each lysate of B16F0 melanoma cells and C57BL/6J mice skin was measured at 405 nm and compared with a standard curve of known concentrations of synthetic melanin. The amounts of protein in the above lysates were determined using the BCA TM Protein Assay Kit. Each value was calculated as the melanin content per mg protein (mg/mg protein) to compensate for differences between samples.
Western Blot Analysis After measurement of the amount of protein in each sample, equal amounts of protein from each lysate (3 mg/lane for B16F0 melanoma cells, 20 mg/lane for C57BL/6J mice) were separated on a 10-20% sodium dodecyl sulfate (SDS)-polyacrylamide gradient gel by electrophoresis and transferred to a nitrocellulose membrane. For Western blot analysis of tyrosinase or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein levels, the membranes were blocked in 0.1% Tween-20 phosphate-buffered saline (Tween-PBS) containing 10% skimmed milk for 60 min at room temperature with agitation. Each membrane was then incubated with the primary antibody diluted in Tween-PBS (polyclonal anti-tyrosinase, 1 : 1000 or 1 : 500; polyclonal anti-GAPDH, 1 : 200 or 1 : 500 for B16F0 melanoma cells or C57BL/6J mice, respectively) overnight at room temperature. Each membrane was washed three times for 10 min each with Tween-PBS, followed by 1 h of incubation at room temperature with horseradish peroxidase-conjugated donkey anti-goat IgG antibody diluted to 1 : 5000 in Tween-PBS. After this, each membrane was again washed three times for 10 min each in Tween-PBS. The antigen-antibody peroxidase complex was then detected using Immobilon Western Chemiluminescent HRP Substrate (Millipore, Billerica, MA, U.S.A.), according to the manufacturer's instructions, and visualized by exposure to Hyperfilm (Amersham Biosciences, Buckinghamshire, U.K.). The intensity of each band was analyzed and quantified by computer-assisted densitometry using Scion Image Beta 4.0.2 software. Tyrosinase protein levels within each sample were normalized to the GAPDH protein levels.
Statistical Analysis Data are expressed as meanϮ S.E.M. Significant differences between treatment groups were determined by the F-test, followed by Student's (equal variances) or Aspin-Welch's (unequal variances) t-test (comparison between two groups), or the Bartlett test, followed by parametoric (equal variances) or nonparametric (unequal variances) Dunnett's test (comparison between multiple groups).
RESULTS

Glycine Inhibited a a-MSH-Induced Melanogenesis in B16F0 Melanoma Cells
To determine the effects of glycine on a-MSH-induced melanogenesis in B16F0 melanoma cells, B16F0 melanoma cells were treated with various concentrations of glycine and a-MSH for 72 h. The basal a-MSH-induced melanin production in B16F0 melanoma cells was 59.2Ϯ0.7 mg/mg protein after 72 h incubation. Glycine (1-16 mM) inhibited a-MSH-induced melanogenesis in a concentration-dependent manner, corresponding to 48.8Ϯ0.9 mg/mg protein at 16 mM (Fig. 1) . Glycine at any concentration tested did not have any significant effects on cell proliferation in B16F0 melanoma cells (Fig. 1) . Kojic acid (2.5 mM) also reduced melanin production to 43.1Ϯ2.7 mg/mg protein without changing cell proliferation (Fig. 1) .
Glycine Down-Regulated Tyrosinase Protein Levels in B16F0 Melanoma Cells Seventy-two hours treatment with a-MSH (1 nM) increased the amount of tyrosinase protein levels in B16F0 melanoma cells (Fig. 2) . Treatment with glycine (16 mM) inhibited the a-MSH-induced increment of tyrosinase protein levels to below the basal levels (Fig. 2) . PMA (10 nM) also decreased tyrosinase protein levels (Fig.  2) .
Glycine Inhibited Hair Follicle Melanogenesis in Hair Depilated C57BL/6J Mice After depilation of hair in the C57BL/6J mice, the L* value of the skin increased on day 3 followed by decrement to below the level of day 0, while the C* value decreased progressively from days 0 to 7 (Fig. 3A) . The 5 d treatment with glycine (1250 or 2500 mg/kg, i.p.) prevented the decrement of the L* and C* values in a concentration-dependent manner (Figs. 3A, B) . Hydroquinone (100 mg/kg, i.p.) also prevented the decrement of L* and C* values to the same degree as the highest concentration of glycine (Figs. 3A, B) .
Glycine Down-Regulated Tyrosinase Protein Levels and Decreased the Melanin Content within the Skin of Hair Depilated C57BL/6J Mice Tyrosinase protein levels within the skin on day 0 were low, as shown by the ratio of tyrosinase to GAPDH protein levels, whereas by day 7 it significantly increased (Fig. 4, Table 1 ). The 5 d treatment with 5 cells/well in 6 well plates (0 h) and the cells incubated at 37°C and 5% CO 2 overnight. Kojic acid (KA: 2.5 mM) or each dose of glycine and a-MSH (1 nM) were added to the wells and incubated for another 72 h. After each incubation, cells were dissolved in 400 ml of 1 N NaOH and incubated at 80°C for 1 h. Melanin content and total protein were determined at 405 and 570 nm absorbance respectively. Data express the meanϮS.E.M. of 3 determinations as mg/mg protein for melanin content (column) and mg/ml for total protein (symbol). * pϽ0.05, and * * pϽ0.01 vs. a-MSH alone. 5 cells/well in 6 well plates (0 h) and the cells incubated at 37°C and 5% CO 2 overnight. PMA (10 nM) or glycine (16 mM) and a-MSH (1 nM) were added to the wells and incubated for another 72 h. After each incubation, cells were dissolved in 400 ml of M-PER Mammalian Protein Extraction Reagent with protease inhibitors and the cell lysates were frozen and thawed 5 times. After determining total protein amounts, whole cell lysates were subjected to Western blot analysis with antibodies against tyrosinase (1 : 1000) and GAPDH (1 : 200). (Fig. 4, Table 1 ). Hydroquinone (100 mg/kg, i.p.) also inhibited the increment of tyrosinase protein levels to the same degree as the highest concentration of glycine (Fig. 4 , Table  1 ).
The basal melanin content within the skin on day 0 was 13.0Ϯ0.8 mg/mg protein, whereas by day 7 it increased to 39.9Ϯ2.0 mg/mg protein, similar to tyrosinase protein levels (Fig. 5) . Again, glycine (1250 or 2500 mg/kg, i.p.) inhibited the increment of melanin content in a concentration-dependent manner, corresponding to 33.9Ϯ4.7 or 23.6Ϯ1.8 mg/mg protein, respectively (Fig. 5) . Hydroquinone (100 mg/kg, i.p.) also inhibited the increment of melanin content to the same degree as the highest concentration of glycine (Fig. 5) . All the in vivo data for hair follicle melanogenesis is summarized in Table 1 .
DISCUSSION
Melanogenesis plays an important role in protecting skin from sun-related injury, however it can sometimes produce undesirable problems, such as lentigo, seborrheic keratosis and melasma. 1, [27] [28] [29] Previously, we demonstrated that the simplest amino acid, glycine, inhibits spontaneous melanogenesis in B16F0 melanoma cells. 14) In that study, the inhibitory effect of glycine was similar to that of kojic acid, which is a typical tyrosinase inhibitor. However, kojic acid showed an inhibitory effect on mushroom tyrosinase activity while glycine did not. Thus, the reduced melanogenesis caused by glycine is not the result of a direct inhibitory effect on tyrosinase activity.
Recently, some melanogenesis inhibitors, such as linoleic acid, and terrein (an bioactive fungal metabolite), were also shown to inhibit melanogenesis without changing tyrosinase activity, similar to glycine. 30, 31) Linoleic acid is known to inhibit melanogenesis by acceleration of tyrosinase protein degradation via the ubiquitin-proteasome pathway. 30) On the other hand, terrein is known to inhibit melanogenesis by down-regulating a microphthalmia-associated transcription factor required for tyrosinase expression via extracellular signal-regulated protein kinase activation. 31) Thus, to further examine the mechanisms of glycine inhibition of melanogenesis we examined whether glycine affects tyrosinase protein levels in B16F0 melanoma cells. Treatment with glycine inhibited the a-MSH-induced increment of tyrosinase protein levels without changing the level of the house keeping protein, GAPDH. Moreover, the protein levels of tyrosinase in the glycine-treated B16F0 melanoma cells were lower than the control levels. These results suggest that glycine causes the inhibition of melanogenesis by down-regulation of tyrosinase protein levels in B16F0 melanoma cells. Thus, glycine has a unique mechanism of melanogenesis inhibition, as do linoleic acid and terrein.
In the present study, the depilation of hair in C57BL/6J mice caused the decrement of L* and C* values in the skin to below the control levels. Therefore, the decrement of the L* and C* values most likely reflects skin pigmentation along with an increment in hair follicle melanogenesis and tyrosinase activity. These changes were also associated with an increment in melanin content and tyrosinase protein levels within the skin after depilation of hair. The anagen phase is strictly coupled to hair follicle melanogenesis, which correlates with tyrosinase levels and enzyme activity. 32) Therefore, the present results are consistent with previous reports. Moreover, hydroquinone, a phenolic derivative, showed an obvious hypopigmenting effect in this model. It is widely believed that phenolic derivatives are effective to this model and that these agents inhibit the anagen phase of hair follicle melanogenesis. 22, 33) This evidence is supported by our findings that hydroquinone showed a hypopigmenting effect that was mediated by inhibition of both melanin content and tyrosinase protein levels. These results suggest that hair follicle melanogenesis in C57BL/6J mice is a suitable model to investigate in vivo hypopigmentation.
The in vivo administration of glycine to C57BL/6J mice demonstrated a hypopigmenting effect, similar to hydroquinone. The effects of glycine on pigmentation may be ex- plained by the down-regulation of tyrosinase protein levels followed by the decrement of melanin content in the skin. The present in vivo data corresponds perfectly with the finding that glycine inhibits a-MSH-induced melanogenesis and down-regulates tyrosinase protein levels in B16F0 melanoma cells. Therefore, this is the first evidence to suggest that glycine also exerts these same properties in vivo.
The mechanism of glycine decrement of tyrosinase protein levels does not appear to involve the glycine receptor, as strychnine, which is an antagonist of the glycine receptor, did not influence the inhibitory effect of glycine on melanogenesis in B16F0 melanoma cells. Furthermore, a-MSH-induced tyrosinase mRNA expression was not influenced by glycine, as determined by qualitative reverse transcription-polymerase chain reaction analysis (both unpublished observations). Therefore, it is likely that these effects of glycine are not mediated by the glycine receptor and are related to post-transcriptional or other events. However, further research is required to clarify the mechanism involved.
In the clinical field, hydroquinone can be compounded into 5-10% concentrations and the most commonly used treatment is topical. 34) However, hydroquinone may cause irritation and be unstable at these strengths. 34) Moreover, hair follicle melanogenesis is induced by the depilation of hair, suggesting that hypopigmenting agents penetrate into pores, producing adverse effects. Therefore, we chose a systemic administration route.
A previous report demonstrated that dietary glycine inhibits the growth of melanoma tumors using much higher glycine dose (5% glycine, 10 g/kg body weight) than in the present study with no affect on food consumption or body weight gain in mice. 13) Similarly, in the present study the repeated administration of glycine for 5 d did not influence body weight gain, except for on day 5 at the higher concentration. The regulatory mechanism of hair follicle melanogenesis in C57BL/6J mice is derived from its complex genetic background, for instance, agouti locus alleles.
35) The phenomenon of anagen-coupled melanogenesis is exactly what happens after depilation of hair, and thus controlling melanogenesis using simple hypopigmenting agents, such as glycine, is difficult. In fact, we also needed to use quit a high dose of hydroquinone as the positive control. Therefore the dose of glycine in this study might be adequate to control hair follicle melanogenesis in C57BL/6J mice.
The present doses of glycine in vivo model were considerably high and not realistic in clinical use. Therefore, more investigation is required to define whether a low dose of glycine might inhibit melanogenesis in a mild model, such as UV-induced melanogenesis in brownish guinea pigs. Alternatively, further investigation needs to identify whether a combination of glycine and other hypopigmenting agents might show an additive effect on melanogenesis. It has been demonstrated that the contents of amino acids within a skin plays an important role in regulating the hydration state of the skin surface. 36, 37) If glycine affects at low doses and has an additive effect, it might be useful for a supplement of hypopigmenting agents, which not only can inhibit melanogenesis but also keep moisture within a skin. Even if the doses of glycine are high, there is no available report of hypopigmenting effect in vivo. It is well known that glycine is welltolerated with few adverse effects. Thus, it is intriguing to exploit the possibility of clinical usability by the further investigations.
In summary, we investigated the hypopigmenting effect of glycine and found that glycine has an inhibitory effect on a-MSH-induced melanogenesis without any influence on cell proliferation in B16F0 melanoma cells. Moreover, glycine caused the hypopigmenting effect during the anagen phase, which was induced by the depilation of hair in C57BL/6J mice. These hypopigmenting observations are consistent with the inhibition of tyrosinase protein levels and melanin content within the skin. Thus, the simplest amino acid, glycine, has the potential to be a melanogenesis inhibitor.
